Angiotensin converting enzyme

Species : Human Assay Principle : Quantitative Target Name : Angiotensin converting enzyme Sensitivity : 0.01ng/mL Detection Range : 0.1 ng/mL -5 ng/mL

Species : Human Assay Principle : Quantitative Target Name : Angiotensin I Converting Enzyme Sensitivity : 1.2 pg/ml Detection Range : 5 pg/ml -260 pg/ml

Species : Human Assay Principle : Quantitative Target Name : angiotension Sensitivity : 4.5 pg/ml Detection Range : 16 pg/ml-600 pg/ml

Size: 1 X 96-Well Strip Microplate Kit Target Name(s): Angiopoietin-1 Accession Number: Q15389 Gene Name(s): ANGPT1, KIAA0003 Gene ID: 284 Species Detected: Human Compatible Sample Types: Cell Culture Supernatants Plasma Serum Sensitivity: 30 pg/ml

Size: 1 X 96-Well Strip Microplate Kit Target Name(s): Chemerin Accession Number: Q99969 Gene Name(s): RARRES2, TIG2 Gene ID: 5919 Species Detected: Human Compatible Sample Types: Cell Culture Supernatants Plasma Serum Sensitivity: 0.5 ng/ml

An ELISA kit for the detection of ANG2 (Rabbit). This uses Sandwich ELISA, Double Antibody and has a sensitivity of 46.875pg/ml.

L-Arginine is an essential amino acid and precursor of nitric oxide synthesis that induces vasodilation in vivo. Nitric oxide potentiates insulin-mediated glucose uptake through the increase in blood flow. A precursor of nitric oxide synthesis that

L-Arginine is an essential amino acid and precursor of nitric oxide synthesis that induces vasodilation in vivo. Nitric oxide potentiates insulin-mediated glucose uptake through the increase in blood flow. A precursor of nitric oxide synthesis that

L-Arginine is an essential amino acid and precursor of nitric oxide synthesis that induces vasodilation in vivo. Nitric oxide potentiates insulin-mediated glucose uptake through the increase in blood flow. A precursor of nitric oxide synthesis that

ACE2 (Cell-free assay): CPDA (Cell-free assay) 0.44 nM: 27 μMIn vitroconversion from angiotensin II to angiotensin-(1–7) by mouse ACE2 is blocked by MLN-4760 (10 μM). MLN-4760 inhibits both human and mouse ACE2 activity. In huMNCs, MLN-4760-B (an

ACE2 (Cell-free assay): CPDA (Cell-free assay) 0.44 nM: 27 μMIn vitroconversion from angiotensin II to angiotensin-(1–7) by mouse ACE2 is blocked by MLN-4760 (10 μM). MLN-4760 inhibits both human and mouse ACE2 activity. In huMNCs, MLN-4760-B (an

ACE2 (Cell-free assay): CPDA (Cell-free assay) 0.44 nM: 27 μMIn vitroconversion from angiotensin II to angiotensin-(1–7) by mouse ACE2 is blocked by MLN-4760 (10 μM). MLN-4760 inhibits both human and mouse ACE2 activity. In huMNCs, MLN-4760-B (an